NCT06034197 2026-04-08
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Stanford University
Phase EARLY_PHASE1 Terminated
Clinical Trials
32 trialsNCT02724202 2026-02-06
Curcumin in Combination With 5FU for Colon Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Terminated
NCT05841706 2025-06-10
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
NCT04213794 2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1 Terminated
NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03492164 2024-06-12
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT03812562 2024-02-21
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Northwestern University
Phase EARLY_PHASE1 Terminated
NCT04150874 2023-04-10
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Terminated
NCT04777708 2023-03-24
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03280277 2021-09-10
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Terminated
NCT03515941 2020-10-12
GABLE
Baylor College of Medicine
Phase EARLY_PHASE1 Terminated
NCT03600623 2020-08-18
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
University of Alabama at Birmingham
Phase EARLY_PHASE1 Terminated
NCT03890198 2020-07-02
A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Terminated
NCT00091286 2020-03-30
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT01413451 2019-12-17
Amatuximab for High Mesothelin Cancers
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT02374931 2019-10-03
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00414570 2019-08-28
An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
AHS Cancer Control Alberta
Phase EARLY_PHASE1 Terminated
NCT03481920 2019-08-22
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer
PH Research, S.L.
Phase EARLY_PHASE1 Terminated
NCT01276613 2019-05-02
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01445054 2019-03-11
111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT00364364 2019-01-18
Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT00499733 2019-01-18
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT00867126 2018-11-26
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT02089386 2017-03-13
Tamoxifen to Treat Barrett's Metaplasia
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated
NCT02080416 2016-06-10
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT01962909 2016-03-18
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT01384240 2016-01-12
Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia
Anandasabapathy, Sharmila, M.D.
Phase EARLY_PHASE1 Terminated
NCT01384695 2016-01-12
A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
Anandasabapathy, Sharmila, M.D.
Phase EARLY_PHASE1 Terminated
NCT00835679 2014-05-23
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated
NCT01337492 2012-03-21
Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated